Patents by Inventor Preeyam S. PATEL

Preeyam S. PATEL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Selective inhibition of T follicular helper cells for treatment of autoimmune disorders
    Patent number: 12168003
    Abstract: Disclosed herein is a method of inhibiting T Follicular Helper (TFH) cell-mediated differentiation and/or activation in a subject. This method involves administering to a subject in need of treatment for an autoimmune disorder a eukaryotic translation initiation factor 4E (eIF4E) inhibitor to inhibit TFH cell-mediated differentiation and/or activation in the subject. Also disclosed is a method of inhibiting T Follicular Helper (THF) cell differentiation or TFH cell activity.
    Type: Grant
    Filed: February 6, 2023
    Date of Patent: December 17, 2024
    Assignee: NEW YORK UNIVERSITY
    Inventors: Preeyam S. Patel, Robert J. Schneider
  • SELECTIVE INHIBITION OF T FOLLICULAR HELPER CELLS FOR TREATMENT OF AUTOIMMUNE DISORDERS
    Publication number: 20230233535
    Abstract: Disclosed herein is a method of inhibiting T Follicular Helper (TFH) cell-mediated differentiation and/or activation in a subject. This method involves administering to a subject in need of treatment for an autoimmune disorder a eukaryotic translation initiation factor 4E (eIF4E) inhibitor to inhibit TFH cell-mediated differentiation and/or activation in the subject. Also disclosed is a method of inhibiting T Follicular Helper (THF) cell differentiation or TFH cell activity.
    Type: Application
    Filed: February 6, 2023
    Publication date: July 27, 2023
    Inventors: Preeyam S. PATEL, Robert J. SCHNEIDER
  • Selective inhibition of T Follicular Helper cells for treatment of autoimmune disorders
    Patent number: 11602524
    Abstract: Disclosed herein is a method of inhibiting T Follicular Helper (TFH) cell-mediated differentiation and/or activation in a subject. This method involves administering to a subject in need of treatment for an autoimmune disorder a eukaryotic translation initiation factor 4E (eIF4E) inhibitor to inhibit TFH cell-mediated differentiation and/or activation in the subject. Also disclosed is a method of inhibiting T Follicular Helper (THF) cell differentiation or TFH cell activity.
    Type: Grant
    Filed: December 2, 2020
    Date of Patent: March 14, 2023
    Assignee: NEW YORK UNIVERSITY
    Inventors: Preeyam S. Patel, Robert J. Schneider
  • SELECTIVE INHIBITION OF T FOLLICULAR HELPER CELLS FOR TREATMENT OF AUTOIMMUNE DISORDERS
    Publication number: 20210299105
    Abstract: Disclosed herein is a method of inhibiting T Follicular Helper (TFH) cell-mediated differentiation and/or activation in a subject. This method involves administering to a subject in need of treatment for an autoimmune disorder a eukaryotic translation initiation factor 4E (eIF4E) inhibitor to inhibit TFH cell-mediated differentiation and/or activation in the subject. Also disclosed is a method of inhibiting T Follicular Helper (THF) cell differentiation or TFH cell activity.
    Type: Application
    Filed: December 2, 2020
    Publication date: September 30, 2021
    Inventors: Preeyam S. PATEL, Robert J. SCHNEIDER